1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/33701
Full metadata record
DC FieldValueLanguage
dc.contributor.authorReynolds, Gemma-
dc.contributor.authorAnderson, Mary Ann-
dc.contributor.authorThursky, Karin-
dc.contributor.authorTeh, Benjamin W-
dc.contributor.authorSlavin, Monica A-
dc.date2023-
dc.date.accessioned2023-09-13T04:43:27Z-
dc.date.available2023-09-13T04:43:27Z-
dc.date.issued2023-12-
dc.identifier.citationLeukemia & Lymphoma 2023-12; 64(13)en_US
dc.identifier.issn1029-2403-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/33701-
dc.description.abstractT/Natural killer (NK) cell lymphomas (TCL) represent a heterogenous subgroup of non-Hodgkin lymphoma, associated with poorer prognosis and higher treatment toxicity. A cohesive synthesis of infection outcomes among TCL patients is lacking. International guidelines offer no specific recommendations regarding prophylaxis or supportive infection care for TCL patients. This systematic narrative review highlights infection outcomes in TCL patients treated with conventional, and novel therapies. Recommendations for infection screening, antimicrobial prophylaxis and vaccination strategies are outined.en_US
dc.language.isoeng-
dc.subjectT cell lymphomaen_US
dc.subjectinfectious complicationsen_US
dc.subjectneoplasiaen_US
dc.subjectnovel therapiesen_US
dc.titleRecommendations on prevention of infections in patients with T-cell lymphomas: a narrative review and synthesis.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleLeukemia & Lymphomaen_US
dc.identifier.affiliationDepartment of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.;Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.;National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationDepartment of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationSir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.;National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationNational Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationInfectious Diseasesen_US
dc.identifier.doi10.1080/10428194.2023.2252945en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-9561-3592en_US
dc.identifier.pubmedid37688482-
dc.description.startpage1-
dc.description.endpage14-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

8
checked on Nov 21, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.